Product Safety Recalls

Product Recall Tracker

HYDRALAZINE HYDROCHLORIDE Recall D-0045-2025

Description: Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.

HYDRALAZINE HYDROCHLORIDE Recall D-0045-2025 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0045-2025
Event ID95700
BrandHYDRALAZINE HYDROCHLORIDE
Generic NameHYDRALAZINE HYDROCHLORIDE
ManufacturerHYDRALAZINE HYDROCHLORIDE
Active SubstanceHYDRALAZINE HYDROCHLORIDE
Drug RouteORAL
DistributionNationwide in the US.
Quantity25814 tablets
Recall ReasonFailed impurities/degradation specifications during routine stability testing for impurities.
Drug ClassificationClass III
Drug Code Info20241120
Product NDC0904-6441 0904-6440 0904-6442
Recall Initiation Date20241105
Report Date20241120
Classification Date20241114
Address341 Mason RdN/A
La Vergne, TN 37086-3606
United States
Recalling FirmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Initial Notification Letter
Unique Ingredient IdentifierFD171B778Y
Drug Application NumberANDA086242
Structured Product Labeling (SPL ID)b3e6cf2f-1dd6-4d0a-b687-423da164b209
Structured Product Labeling (SPL Set ID)7dc7c11b-ac51-4db3-ac6a-708c676a8859
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.